PrecisionMed specializes in providing high-quality human biological materials essential for advancing research in genetics, drug discovery, biomarker research, and molecular diagnostics. The company boasts the largest commercially available biorepository of human cerebrospinal fluid (CSF) globally, offering a diverse inventory that includes CSF samples, liquid biopsies, and various human tissues. These samples are collected under IRB-approved clinical protocols, ensuring compliance with regulatory standards. PrecisionMed's predictive biobanking approach allows for the immediate availability of samples, which are longitudinally collected and well-characterized, thus facilitating timely research and development efforts for its clients, which include major pharmaceutical companies and academic institutions.

In addition to its extensive biorepository, PrecisionMed supports various research initiatives, including liquid biopsy studies aimed at early cancer detection and in vitro diagnostics to address the rising demand for chronic disease testing. The company emphasizes the importance of high-quality biospecimens, implementing standardized collection procedures and rigorous quality control measures to guarantee the integrity of its samples. With over 120 citations in scientific journals, PrecisionMed is recognized as a trusted source for biological materials, contributing significantly to advancements in medical research and diagnostics.

United States

PrecisionMed is a provider of products and services supporting advancements in genetics, drug discovery, biomarker research, and molecular diagnostics with a focus on high-quality human biological material.

PrecisionMed

Company Details